Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Insensitivity to insulin, also called insulin resistance, is associated with type 2 diabetes and affects several cell types and organs in the body. Now, scientists from Sweden’s Karolinska Institutet have discovered a mechanism that explains how insulin-producing cells can be insulin resistant and insulin sensitive at the same time. The findings are being published in the journal Cell Reports, and may lead to future novel treatment strategies for type 2 diabetes.

  • Jubilant DraxImage Inc. (DraxImage), a subsidiary of Jubilant Life Sciences and Cyclopharm Limited (CYC), provider of innovative solutions in nuclear medicine signed a term sheet  to market and distribute Technegas in the United States. DraxImage will assist CYC with the development and financing of the phase III clinical trials for Technegas, and any other steps required to file for and obtain US FDA approval.

  • Cancer Research UK scientists have found how cells adapt to overcome cancer drugs designed to interfere with their genetic controls, according to a study published today (Wednesday) in Epigenetics and Chromatin.

    [adsense:336x280:8701650588]

  • Food craving may be 'hard-wired' in the brain of overweight patients, say scientists who found that obesity is associated with neural changes similar to those found in substance addiction.

  • A new group of antibiotics that may provide relief to people affected by antibiotic resistance, has been developed by a team of researchers from Virginia Institute of Technology. These new antibiotics can successfully target the bacteria Staphylococcus aureus (staph) and the antibiotic-resistant strains commonly known as methicillin-resistant Staphylococcus aureus (MRSA). The paper was published in Medicinal Chemistry Communications.

  • Scientists from University of Iowa found two natural compounds one found in apples and one in green tomatoes, which reduce the protein's activity in aged muscle. The protein called ATF4 alters gene expression in skeletal muscle, causing reduction of muscle protein synthesis, strength and mass.

  • Biocon Ltd. Asia's premier biopharmaceuticals company, inaugurated a world class facility for manufacturing new generation, patient-friendly devices for its insulins portfolio. The facility was inaugurated by Mr. Amitabh Kant, Secretary, Department of Industrial Promotion and Policy, Govt. of India along with Mr. Kaushik Mukherjee, Chief Secretary, Government of Karnataka and Ms. V. Manjula, Secretary, IT,BT and S&T, Government of Karnataka. Mr Kant also launched Basalog One™, a high-end, ready-to-use insulin glargine disposable pen for better blood sugar management for people with diabetes, manufactured in this facility.

Subscribe to Pharma News